The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating-free DNA (cfDNA) as biomarker of taxane resistance in metastatic castration-resistant prostate cancer (mCRPC).
 
Edoardo Francini
Honoraria - Janssen-Cilag
Research Funding - Roche
Travel, Accommodations, Expenses - Janssen-Cilag
 
Fang-Shu Ou
No Relationships to Disclose
 
Justin Rhoades
No Relationships to Disclose
 
Eric G. Wolfe
No Relationships to Disclose
 
Edward O'Connor
No Relationships to Disclose
 
Gavin Ha
No Relationships to Disclose
 
Gydush Gregory
No Relationships to Disclose
 
Kaitlin Kelleher
No Relationships to Disclose
 
Rupal Satish Bhatt
Patents, Royalties, Other Intellectual Property - Patent Filed for novel RCC treatments (Inst)
 
Steven P. Balk
Stock and Other Ownership Interests - NKT Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Constellation Pharmaceuticals; Janssen Biotech; Kronos; Sanofi
Patents, Royalties, Other Intellectual Property - License to NKT Therapeutics for an antibody
Expert Testimony - Astellas Medivation
Travel, Accommodations, Expenses - Janssen
 
Christopher Sweeney
Stock and Other Ownership Interests - Leuchemix
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Celgene; Genentech/Roche; Janssen Biotech; Lilly; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon; Janssen Biotech (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination
 
Viktor Adalsteinsson
No Relationships to Disclose
 
Mary-Ellen Taplin
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Celgene; Clovis Oncology; Guidepoint Global; Incyte; Janssen-Ortho; Merck; Pfizer; Progenics; Research to Practice; UpToDate
Consulting or Advisory Role - AstraZeneca; Bayer; Best Doctors, Inc; Clovis Oncology; Guidepoint Global; Incyte; Janssen-Ortho; Myovant Sciences; Pfizer; Research to Practice; UpToDate
Research Funding - Bayer (Inst); Janssen-Ortho (Inst); Medivation (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Clovis Oncology; Incyte; Janssen Oncology; Medivation; Pfizer; Tokai Pharmaceuticals
 
Atish Dipankar Choudhury
Employment - LeMaitre Vascular (I)
Honoraria - Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen (Inst)
Travel, Accommodations, Expenses - Genentech